Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides finished dosage formulation in therapeutic areas, such as nutrition, pain management, parasite control, antibiotics, and gut health for livestock, poultry, and companion animals. It also offers analytical services; and VET formulation services. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.
| Current Price | ₹250.05 |
|---|---|
| Market Cap | ₹10,914 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Pharmaceutical Contract Research Organization |
| P/E Ratio | 62.4 |
| Return on Equity | 11.56% |
| Beta (1Y) | 0.65 |
| Dividend Yield | 0.00% |
1. Pharmaceuticals-100%
Sequent Scientific Ltd is trading at ₹250.05, with a market capitalisation of ₹10,914 Cr.
Sequent Scientific Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Research Organization).
Sequent Scientific Ltd has a P/E of 62.4 and a return on equity of 11.56%.